Attached files
| file | filename |
|---|---|
| EX-11 - EXHIBIT 11 - NOVELION THERAPEUTICS INC. | c97388exv11.htm |
| EX-23 - EXHIBIT 23 - NOVELION THERAPEUTICS INC. | c97388exv23.htm |
| EX-21 - EXHIBIT 21 - NOVELION THERAPEUTICS INC. | c97388exv21.htm |
| EX-31.2 - EXHIBIT 31.2 - NOVELION THERAPEUTICS INC. | c97388exv31w2.htm |
| EX-31.1 - EXHIBIT 31.1 - NOVELION THERAPEUTICS INC. | c97388exv31w1.htm |
| EX-32.2 - EXHIBIT 32.2 - NOVELION THERAPEUTICS INC. | c97388exv32w2.htm |
| 10-K - FORM 10-K - NOVELION THERAPEUTICS INC. | c97388e10vk.htm |
EXHIBIT 32.1
CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of QLT Inc. (the “Company”), on Form 10-K for the fiscal year
ended December 31, 2009 as filed with the Securities and Exchange Commission (the “Report”), I,
Robert L. Butchofsky, President and Chief Executive Officer of the Company, hereby certify as of
the date hereof, solely for purposes of 18 U.S.C. §1350, as adopted pursuant to §906 of the
Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d), as
applicable, of the Securities Exchange Act of 1934; and |
||
| (2) | The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company at the dates
and for the periods indicated. |
Dated: March 10, 2010
| /s/ Robert L. Butchofsky | ||||
| Robert L. Butchofsky | ||||
| President and Chief Executive Officer (Principal Executive Officer) QLT Inc. |
||||